Test ID: CAHBS
Congenital Adrenal Hyperplasia (CAH) Newborn Screening, Blood Spot
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Second-tier testing of newborns with abnormal screening result for congenital adrenal hyperplasia
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Second-tier newborn screen.
Method Name A short description of the method used to perform the test
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
CAH Newborn Screening, BS
Aliases Lists additional common names for a test, as an aid in searching
11-beta-Hydroxylase Deficiency
17 OHP (17-Hydroxyprogesterone)
17-Hydroxyprogesterone
17-OHP (17-Hydroxyprogesterone)
21 Hydroxylase Deficiency
21-Hydroxylase Deficiency
Blood Spots
CAH (Congenital Adrenal Hyperplasia)
Congenital Adrenal Hyperplasia (CAH)
Newborn Screen
17 OHP (17-Hydroxyprogesterone)
17-Hydroxyprogesterone
17-OHP (17-Hydroxyprogesterone)
21 Hydroxylase Deficiency
21-Hydroxylase Deficiency
Blood Spots
CAH (Congenital Adrenal Hyperplasia)
Congenital Adrenal Hyperplasia (CAH)
Newborn Screen
External
link
PDF
document
Excel
document
Word
document